SEC Form 4 · accession 0001127602-17-001434
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Pangia
Director
Period of report
Jan 9, 2017
Accepted (ET)
Jan 10, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2017 | M | 5,450 | $52.22 | A | 22,078 | D | |
| Common Stock | Jan 9, 2017 | S | 5,450 | $295.39 | D | 16,628 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $52.22 | Jan 9, 2017 | M | 5,450 | D | — | May 30, 2017 | Common Stock | 5,450 | 0 | D |
Explanation of responses
- F1Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.